Influence of Genetic Polymorphisms in the Glutamatergic and GABAergic Systems and Their Interactions with Environmental Stressors on Antidepressant Response

• Caspi A , SugdenK, MoffittTE et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301(5631) , 386–389 (2003).
   PubMed Web of Science ®Google Scholar
• Horstmann S , BinderEB. Pharmacogenomics of antidepressant drugs. Pharmacol. Ther.124(1) , 57–73 (2009).
   PubMed Web of Science ®Google Scholar
• Hashimoto K . The role of glutamate on the action of antidepressants. Prog. Neuropsychopharmacol. Biol. Psychiatry35(7) , 1558–1568 (2011).
   PubMed Web of Science ®Google Scholar
• Zarate CA Jr, Singh JB, Carlson PJ et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry63(8) , 856–864 (2006).
   PubMed Web of Science ®Google Scholar
• Hasler G , van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry64(2) , 193–200 (2007).
   PubMed Web of Science ®Google Scholar
• Gorman JM . New molecular targets for antianxiety interventions. J. Clin. Psychiatry64(Suppl. 3) , 28–35 (2003).
   PubMedGoogle Scholar
• Tokarski K , BobulaB, WabnoJ, HessG. Repeated administration of imipramine attenuates glutamatergic transmission in rat frontal cortex. Neuroscience153(3) , 789–795 (2008).
   PubMed Web of Science ®Google Scholar
• Krystal JH , SanacoraG, BlumbergH et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol. Psychiatry 7(Suppl. 1) , S71–S80 (2002).
   PubMed Web of Science ®Google Scholar
• Lin E , ChenPS. Pharmacogenomics with antidepressants in the STAR*D study. Pharmacogenomics9(7) , 935–946 (2008).
   PubMed Web of Science ®Google Scholar
• Laje G , PaddockS, ManjiH et al. Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. Am. J. Psychiatry 164(10) , 1530–1538 (2007).
   PubMed Web of Science ®Google Scholar
• El Hage W , PowellJF, SurguladzeSA. Vulnerability to depression: what is the role of stress genes in gene × environment interaction? Psychol. Med.39(9) , 1407–1411 (2009).
   PubMed Web of Science ®Google Scholar
• Schosser A , KasperS. The role of pharmacogenetics in the treatment of depression and anxiety disorders. Int. Clin. Psychopharmacol.24(6) , 277–288 (2009).
   PubMed Web of Science ®Google Scholar
• Luscher B , ShenQ, SahirN. The GABAergic deficit hypothesis of major depressive disorder. Mol. Psychiatry16(4) , 383–406 (2011).
   PubMed Web of Science ®Google Scholar
• Musazzi L , MilaneseM, FariselloP et al. Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants. PLoS ONE 5(1) , e8566 (2010).
   PubMed Web of Science ®Google Scholar
• Musazzi L , MalleiA, TarditoD et al. Early-life stress and antidepressant treatment involve synaptic signaling and Erk kinases in a gene–environment model of depression. J. Psychiatr. Res. 44(8) , 511–520 (2010).
   PubMed Web of Science ®Google Scholar
• Xu Z , ZhangZ, ShiY et al. Influence and interaction of genetic polymorphisms in catecholamine neurotransmitter systems and early life stress on antidepressant drug response. J. Affect. Disord. 133(1–2) , 165–173 (2011).
   PubMed Web of Science ®Google Scholar
• Xu Z , ZhangZ, ShiY et al. Influence and interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response. J. Psychopharmacol. 26(3) , 349–359 (2011).
   PubMed Web of Science ®Google Scholar
• Shi Y , YuanY, XuZ et al. Genetic variation in the calcium/calmodulin-dependent protein kinase (CaMK) pathway is associated with antidepressant response in females. J. Affect. Disord. 136(3) , 558–566 (2012).
   PubMed Web of Science ®Google Scholar
• Pickar D , RubinowK. Pharmacogenomics of psychiatric disorders. Trends Pharmacol. Sci.22(2) , 75–83 (2001).
   PubMed Web of Science ®Google Scholar
• Bauer M , WhybrowPC, AngstJ, VersianiM, MollerHJ. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: acute and continuation treatment of major depressive disorder. World J. Biol. Psychiatry3(1) , 5–43 (2002).
   PubMedGoogle Scholar
• Bernstein DP , SteinJA, NewcombMD et al. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl. 27(2) , 169–190 (2003).
   PubMed Web of Science ®Google Scholar
• Thombs BD , BernsteinDP, LobbestaelJ, ArntzA. A validation study of the Dutch Childhood Trauma Questionnaire-Short Form: factor structure, reliability, and known-groups validity. Child Abuse Negl.33(8) , 518–523 (2009).
   PubMed Web of Science ®Google Scholar
• Fu W , YaoS, YuH et al. Initial reliability and validity of Childhood Trauma Questionnaire (CTQ-SF) apllied in Chinese college students. Chinese Journal of Clinical Psychology 13(1) , 40–42 (2005).
   Google Scholar
• Sun N , XuY, WangY et al. The combined effect of norepinephrine transporter gene and negative life events in major depression of Chinese Han population. J. Neural Transm. 115(12) , 1681–1686 (2008).
   PubMed Web of Science ®Google Scholar
• Taylor C , FrickerAD, DeviLA, GomesI. Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways. Cell. Signal.17(5) , 549–557 (2005).
   PubMed Web of Science ®Google Scholar
• Pilc A , ChakiS, NowakG, WitkinJM. Mood disorders: regulation by metabotropic glutamate receptors. Biochem. Pharmacol.75(5) , 997–1006 (2008).
   PubMed Web of Science ®Google Scholar
• Skolnick P . AMPA receptors: a target for novel antidepressants? Biol. Psychiatry63(4) , 347–348 (2008).
   PubMed Web of Science ®Google Scholar
• Machado-Vieira R , SalvadoreG, DiazgranadosN et al. New therapeutic targets for mood disorders. ScientificWorldJournal 10 , 713–726 (2010).
   PubMed Web of Science ®Google Scholar
• Zarate C Jr, Machado-Vieira R, Henter I, Ibrahim L, Diazgranados N, Salvadore G. Glutamatergic modulators: the future of treating mood disorders? Harv. Rev. Psychiatry18(5) , 293–303 (2010).
   PubMed Web of Science ®Google Scholar
• Dudbridge F . Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol.25(2) , 115–121 (2003).
   PubMed Web of Science ®Google Scholar
• Lou XY , ChenGB, YanL et al. A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am. J. Hum. Genet. 80(6) , 1125–1137 (2007).
   PubMed Web of Science ®Google Scholar
• Paddock S , LajeG, CharneyD et al. Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort. Am. J. Psychiatry 164(8) , 1181–1188 (2007).
   PubMed Web of Science ®Google Scholar
• Liou YJ , ChenTJ, TsaiSJ, YuYW, ChengCY, HongCJ. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment. Pharmacogenet. Genomics19(10) , 735–741 (2009).
   PubMed Web of Science ®Google Scholar
• Pickard BS , MalloyMP, ChristoforouA et al. Cytogenetic and genetic evidence supports a role for the kainate-type glutamate receptor gene, GRIK4, in schizophrenia and bipolar disorder. Mol. Psychiatry 11(9) , 847–857 (2006).
   PubMed Web of Science ®Google Scholar
• Yamada K , WatanabeA, Iwayama-ShigenoY, YoshikawaT. Evidence of association between gamma-aminobutyric acid type A receptor genes located on 5q34 and female patients with mood disorders. Neurosci. Lett.349(1) , 9–12 (2003).
   PubMed Web of Science ®Google Scholar
• Smith TA . Type A gamma-aminobutyric acid (GABAA) receptor subunits and benzodiazepine binding: significance to clinical syndromes and their treatment. Br. J. Biomed. Sci.58(2) , 111–121 (2001).
   PubMed Web of Science ®Google Scholar
• Hedblom E , KirknessEF. A novel class of GABAA receptor subunit in tissues of the reproductive system. J. Biol Chem.272(24) , 15346–15350 (1997).
   PubMed Web of Science ®Google Scholar
• Yamada S , YamamotoM, OzawaH, RiedererP, SaitoT. Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder. J. Neural Transm.110(6) , 671–680 (2003).
   PubMed Web of Science ®Google Scholar
• Rupprecht R , Di Michele F, Hermann B et al. Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology. Brain Res. Brain Res. Rev.37(1–3) , 59–67 (2001).
   PubMedGoogle Scholar
• Lambert JJ , BelelliD, Hill-VenningC, PetersJA. Neurosteroids and GABAA receptor function. Trends Pharmacol. Sci.16(9) , 295–303 (1995).
   PubMed Web of Science ®Google Scholar
• Massat I , SoueryD, Del-FaveroJ et al. Excess of allele1 for alpha3 subunit GABA receptor gene (GABRA3) in bipolar patients: a multicentric association study. Mol. Psychiatry 7(2) , 201–207 (2002).
   PubMed Web of Science ®Google Scholar
• Buttenschon HN , LauritsenMB, El Daoud A et al. A population-based association study of glutamate decarboxylase 1 as a candidate gene for autism. J. Neural Transm.116(3) , 381–388 (2009).
   PubMed Web of Science ®Google Scholar
• Marenco S , SavostyanovaAA, van der Veen JW et al. Genetic modulation of GABA levels in the anterior cingulate cortex by GAD1 and COMT. Neuropsychopharmacology35(8) , 1708–1717 (2010).
   PubMed Web of Science ®Google Scholar
• Akbarian S , HuangHS. Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res. Rev.52(2) , 293–304 (2006).
   PubMedGoogle Scholar
• McGuffin P , KnightJ, BreenG et al. Whole genome linkage scan of recurrent depressive disorder from the depression network study. Hum. Mol. Genet. 14(22) , 3337–3345 (2005).
   PubMed Web of Science ®Google Scholar
• Davies PA , HannaMC, HalesTG, KirknessEF. Insensitivity to anaesthetic agents conferred by a class of GABA(A) receptor subunit. Nature385(6619) , 820–823 (1997).
   PubMed Web of Science ®Google Scholar
• Belelli D , CasulaA, LingA, LambertJJ. The influence of subunit composition on the interaction of neurosteroids with GABA(A) receptors. Neuropharmacology43(4) , 651–661 (2002).
   PubMed Web of Science ®Google Scholar
• Thompson SA , BonnertTP, CagettiE, WhitingPJ, WaffordKA. Overexpression of the GABA(A) receptor epsilon subunit results in insensitivity to anaesthetics. Neuropharmacology43(4) , 662–668 (2002).
   PubMed Web of Science ®Google Scholar
• Keers R , UherR, GuptaB et al. Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP. J. Affect. Disord. 127(1–3) , 337–342 (2010).
   PubMed Web of Science ®Google Scholar
• Miniati M , RucciP, BenvenutiA et al. Clinical characteristics and treatment outcome of depression in patients with and without a history of emotional and physical abuse. J. Psychiatr. Res. 44(5) , 302–309 (2010).
   PubMed Web of Science ®Google Scholar
• Nemeroff CB , ValeWW. The neurobiology of depression: inroads to treatment and new drug discovery. J. Clin. Psychiatry66(Suppl. 7) , 5–13 (2005).
   PubMed Web of Science ®Google Scholar
• Seal RP , EdwardsRH. Functional implications of neurotransmitter co-release: glutamate and GABA share the load. Curr. Opin. Pharmacol.6(1) , 114–119 (2006).
   PubMed Web of Science ®Google Scholar
• Kawaguchi SY , HiranoT. Sustained structural change of GABA(A) receptor-associated protein underlies long-term potentiation at inhibitory synapses on a cerebellar Purkinje neuron. J. Neurosci.27(25) , 6788–6799 (2007).
   PubMed Web of Science ®Google Scholar
• Sanderson TM , CotelMC, O‘NeillMJ, TricklebankMD, CollingridgeGL, SherE. Alterations in hippocampal excitability, synaptic transmission and synaptic plasticity in a neurodevelopmental model of schizophrenia. Neuropharmacology62(3) , 1349–1358 (2012).
   PubMed Web of Science ®Google Scholar
• Keers R , UherR, Huezo-DiazP et al. Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project. Pharmacogenomics J. 11(2) , 138–145 (2011).
   PubMed Web of Science ®Google Scholar
• Mandelli L , MarinoE, PirovanoA et al. Interaction between SERTPR and stressful life events on response to antidepressant treatment. Eur. Neuropsychopharmacol. 19(1) , 64–67 (2009).
   PubMed Web of Science ®Google Scholar
• Bukh JD , BockC, VinbergM, WergeT, GetherU, KessingLV. No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatment. Eur. Neuropsychopharmacol.20(5) , 327–335 (2010).
   PubMed Web of Science ®Google Scholar
• Barbon A , PopoliM, La Via L et al. Regulation of editing and expression of glutamate alpha-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs. Biol. Psychiatry59(8) , 713–720 (2006).
   PubMed Web of Science ®Google Scholar
• de Kloet ER , JoelsM, HolsboerF. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci.6(6) , 463–475 (2005).
   PubMed Web of Science ®Google Scholar
• Hammen C , BrennanPA, Keenan-MillerD, HazelNA, NajmanJM. Chronic and acute stress, gender, and serotonin transporter gene–environment interactions predicting depression symptoms in youth. J. Child Psychol. Psychiatry51(2) , 180–187 (2010).
   PubMed Web of Science ®Google Scholar

▪ Websites

• International HapMap Project. http://hapmap.ncbi.nlm.nih.gov/cgi-perl/gbrowse/hapmap24_B36/
   Google Scholar
• Database of SNPs and multiple small-scale variations. www.ncbi.nlm.nih.gov/sites/entrez?db=snp
   Google Scholar
• dbSNP short genetic variations. www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=refSNP
   Google Scholar
• HaploView 4.0. http://sourceforge.net/projects/haploview
   Google Scholar
• UNPHASED-3.0.13 software. http://sourceforge.net/projects/unphased
   Google Scholar